Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Glg1em1/Cya
Common Name:
Glg1-KO
Product ID:
S-KO-20017
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Glg1-KO
Strain ID
KOCMP-20340-Glg1-B6J-VB
Gene Name
Glg1
Product ID
S-KO-20017
Gene Alias
CFR; CFR-1; ESL-1; MG-160; MG160; Selel
Background
C57BL/6JCya
NCBI ID
20340
Modification
Conventional knockout
Chromosome
8
Phenotype
MGI:104967
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Glg1em1/Cya mice (Catalog S-KO-20017) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000169020
NCBI RefSeq
NM_009149
Target Region
Exon 13~16
Size of Effective Region
~3.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Glg1, also known as Golgi glycoprotein 1, is an intracellular fibroblast growth factor receptor located in the Golgi apparatus [2]. It is associated with various biological processes and diseases.

In Ewing sarcoma, high BCL11B and/or GLG1 immunoreactivity in CD99-positive cases can help diagnose the disease with high specificity and accuracy, potentially serving as specific auxiliary immunohistochemical markers in conjunction with CD99, especially when confirmatory molecular diagnostics are unavailable [1,8]. In cancer, the drug memantine can suppress the growth of malignant glioma and breast cancer cells, upregulate GLG1 mRNA expression, alter its splicing variant profiles, and change its cellular localization, suggesting that the modulation of GLG1 may be one of the mechanisms underlying memantine's cancer-suppressive effects [2]. In gastric cancer, FUT3 promotes cell migration and invasion by synthesizing Lea on ITGA6 and GLG1, with GLG1 affecting vesicle distribution [3].

In yeast, Glg1, the self-glucosylating initiator of glycogen synthesis, was used as an autophagic reporter. Results showed that glycogen autophagy is a non-selective process in nitrogen-starved Komagataella phaffii yeast as both normal Glg1-GFP and mutated Glg1Y212F-GFP were equally well delivered to the vacuole [4]. In the pathogenic yeast Cryptococcus neoformans, Glg1, which initiates glycogen synthesis, was found to influence the formation of both glycogen and the cell wall, as cells missing Glg1 lack α-1,4-glucan in their walls, indicating a link between glycogen and cell wall material [5].

In mice ovarian granulosa cells, Glg1, a downstream target gene of miR-7a2, is down-regulated by taurine, and Glg1 knockdown increases Cyp19a1 expression and estrogen synthesis, suggesting its role in the p38/miR-7a/Glg1/Cyp19a1 signaling pathway regulating estrogen synthesis [6]. A circular RNA derived from GLG1 mRNA (circ_GLG1) promotes colorectal cancer progression by targeting miR-622 and regulating KRAS expression [7].

In conclusion, Glg1 plays diverse and important roles in various biological processes and diseases. In cancer, it is involved in diagnosis, drug-related mechanisms, and tumor progression. In yeast, it helps understand glycogen autophagy. In the ovary, it is part of the estrogen-regulating pathway. The study of Glg1 in different models provides insights into its functions and potential applications in disease diagnosis and treatment.

References:
1. Orth, Martin F, Hölting, Tilman L B, Dallmayer, Marlene, Kirchner, Thomas, Grünewald, Thomas G P. 2020. High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma. In Cancers, 12, . doi:10.3390/cancers12030644. https://pubmed.ncbi.nlm.nih.gov/32164354/
2. Yamaguchi, Fumio, Hayakawa, Sumio, Kawashima, Shota, Asakura, Takayuki, Oishi, Yumiko. 2022. Antitumor effect of memantine is related to the formation of the splicing isoform of GLG1, a decoy FGF‑binding protein. In International journal of oncology, 61, . doi:10.3892/ijo.2022.5370. https://pubmed.ncbi.nlm.nih.gov/35543162/
3. Wu, Fei, Cao, Li, Zhang, Jinyuan, Qin, Yannan, Huang, Chen. 2024. FUT3 promotes gastric cancer cell migration by synthesizing Lea on ITGA6 and GLG1, affecting adhesion and vesicle distribution. In Life sciences, 359, 123193. doi:10.1016/j.lfs.2024.123193. https://pubmed.ncbi.nlm.nih.gov/39477144/
4. Wijewantha, Nimna V, Kumar, Ravinder, Nazarko, Taras Y. 2024. Glycogen Granules Are Degraded by Non-Selective Autophagy in Nitrogen-Starved Komagataella phaffii. In Cells, 13, . doi:10.3390/cells13060467. https://pubmed.ncbi.nlm.nih.gov/38534311/
5. Loza, Liza, Doering, Tamara L. 2024. A fungal protein organizes both glycogen and cell wall glucans. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2319707121. doi:10.1073/pnas.2319707121. https://pubmed.ncbi.nlm.nih.gov/38743622/
6. Li, Liuhui, Lu, Chenyang, Zhang, Di, Liu, Hui, Cui, Sheng. 2022. Taurine promotes estrogen synthesis by regulating microRNA-7a2 in mice ovarian granulosa cells. In Biochemical and biophysical research communications, 626, 129-134. doi:10.1016/j.bbrc.2022.07.084. https://pubmed.ncbi.nlm.nih.gov/35988296/
7. Hao, Shuhong, Qu, Rongfeng, Hu, Chunmei, Wang, Min, Li, Yarong. 2020. A Circular RNA Derived from Golgi Glycoprotein 1 mRNA Regulates KRAS Expression and Promotes Colorectal Cancer Progression by Targeting microRNA-622. In OncoTargets and therapy, 13, 12637-12648. doi:10.2147/OTT.S284032. https://pubmed.ncbi.nlm.nih.gov/33335404/
8. Baldauf, Michaela C, Orth, Martin F, Dallmayer, Marlene, Kirchner, Thomas, Grünewald, Thomas G P. 2017. Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets. In Oncotarget, 9, 1587-1601. doi:10.18632/oncotarget.20098. https://pubmed.ncbi.nlm.nih.gov/29416716/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest